Martina Garau

Martina Garau

Director

Martina’s current research includes methods and applications of structured decision-making approaches such as Multi-Criteria Decision Analysis (MCDA) in healthcare decision making; economic issues posed by the development and provision of treatments for rare diseases; value based assessments and HTA systems in high and middle income countries. She has over 15 years of experience leading projects for a variety of organisations, including global life sciences companies, non-profit research organisations, charities and trade associations. She has an MSc in Economics from the University of York and a first degree in economics from the University of Cagliari in Italy.

Recent publications:

Cubi-Molla, P., Errea, M., Zhang, K. and Garau, M. (2020). Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making? OHE Consulting report available at https://www.ohe.org/publications/are-cost-effectiveness-thresholds-fit-for-purpose

Chalkidou, K., Garau, M., Silverman, R., and Towse A. (2020). Blueprint for a Market-Driven Value-Based Advance Commitment (MVAC) for Tuberculosis. Center for Global Development. Available at: https://www.cgdev.org/publication/blueprint-market-driven-value-based-advance-commitment-tuberculosis

Garau, M., Hampson, G., Devlin, N. et al. (2018) Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL). PharmacoEconomics Open 2, 153–163 (2018). https://doi.org/10.1007/s41669-017-0048-x

Garau, M. and Devlin, N. (2017). Using MCDA as a decision aid in Health Technology Appraisal for coverage decisions: opportunities, challenges and unresolved questions. In “Multi-Criteria Decision Analysis to Support Healthcare Decisions” Marsh, K., Goetghebeur, M., Thokala, P., Baltussen, R. (Eds.). Springer book available at https://link.springer.com/chapter/10.1007%2F978-3-319-47540-0_14